ro 31-8220 has been researched along with Systemic Inflammatory Response Syndrome in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tiwari, RL | 1 |
| Singh, V | 1 |
| Singh, A | 1 |
| Rana, M | 1 |
| Verma, A | 1 |
| Kothari, N | 1 |
| Kohli, M | 1 |
| Bogra, J | 1 |
| Dikshit, M | 1 |
| Barthwal, MK | 1 |
1 other study available for ro 31-8220 and Systemic Inflammatory Response Syndrome
| Article | Year |
|---|---|
PKCδ-IRAK1 axis regulates oxidized LDL-induced IL-1β production in monocytes.
Topics: Acetophenones; Acetylcysteine; Adult; Benzofurans; Benzopyrans; Carbazoles; Female; Humans; Indoles; | 2014 |